Pharmacy benefit considerations for continuous glucose monitoring acquisition: Vermont Medicaid experience.

Abstract

Many individuals with diabetes are not achieving their glycemic goals. Use of continuous glucose monitoring (CGM) improves diabetes management. Access to CGM is often hindered when individuals must acquire their supplies through the traditional durable medical device channel. Vermont Medicaid transitioned CGM coverage from a medical/durable medical equipment benefit to a pharmacy benefit. This improved access and lessened the burden on prescribing health care providers. We describe the process the Vermont Medicaid program implemented to make this transition. <b>DISCLOSURES:</b> Funding for editorial assistance in the development of this manuscript was provided by Abbott Diabetes Care. The funder had no input in the manuscript content. The authors received no compensation.